Albert Hofmann, Inventor of LSD, Embarks on Final Trip

He was the first person to experience an acid trip--for both good and bad

Join Our Community of Science Lovers!


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Swiss chemist Albert Hofmann, inventor of LSD, died yesterday at the age of 102, just 10 days after the 55th anniversary of his notorious bicycle trip while tripping on "acid". Hofmann, who suffered a heart attack at home in Basel, Switzerland, was the first person to synthesize lysergic acid diethylamide, better known as LSD, and the first human known to experience its mind-bending effects.

The drug was the 25th he created from the basic chemical ingredients of ergot, a fungus that forms on rye, in his search for treatments for circulation and respiratory problems. He reports in his 1979 autobiography LSD, My Problem Child, that he became restless and dizzy when he accidentally ingested the compound while making it—and "perceived an uninterrupted stream of fantastic pictures, extraordinary shapes with intense, kaleidoscopic play of colors" for about two hours.

The very next day (April 19, 1943), he swallowed 0.25 milligram of the acid to confirm that it had caused his odd symptoms. Overcome by dizziness and anxiety, he asked an assistant to bicycle him home; once there, he writes that he was overcome by feelings that he might die (prompting a later call to his physician), along with delusions that included perceiving a kindly neighbor transformed into a malevolent witch.

Sandoz Pharmaceuticals, his employer at the time, tried to promote LSD as a drug to treat psychiatric disorders such as schizophrenia under the trade name Delysid by sending samples to psychiatrists—and the compound was briefly used as the treatment du jour in conjunction with psychoanalysis.

But acid swiftly found its way into wider use among artists, writers (such as Brave New World's Aldous Huxley), actors (including established movie stars like Cary Grant), and rebellious teens in the 1950s and 1960s. In fact, it became so popular as a way to "tune in, turn on and drop out" that in 1966 New York State and California made it a crime to possess it; the U.S. government followed suit in 1970.

Hofmann also manufactured a wide range of medical drugs from ergot, including methergine (which is still used to halt bleeding after birth) and hydergine (which improves circulation). In the psychedelic realm, he was also the first to synthesize psilocybin, the active ingredient in so-called magic mushrooms (Psilocybe mexicana).

It’s Time to Stand Up for Science

If you enjoyed this article, I’d like to ask for your support. Scientific American has served as an advocate for science and industry for 180 years, and right now may be the most critical moment in that two-century history.

I’ve been a Scientific American subscriber since I was 12 years old, and it helped shape the way I look at the world. SciAm always educates and delights me, and inspires a sense of awe for our vast, beautiful universe. I hope it does that for you, too.

If you subscribe to Scientific American, you help ensure that our coverage is centered on meaningful research and discovery; that we have the resources to report on the decisions that threaten labs across the U.S.; and that we support both budding and working scientists at a time when the value of science itself too often goes unrecognized.

In return, you get essential news, captivating podcasts, brilliant infographics, can't-miss newsletters, must-watch videos, challenging games, and the science world's best writing and reporting. You can even gift someone a subscription.

There has never been a more important time for us to stand up and show why science matters. I hope you’ll support us in that mission.

Thank you,

David M. Ewalt, Editor in Chief, Scientific American

Subscribe